Q1 2017 Holdings
Filed 2017-05-15 | 67 holdings | $16.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $4.6M | 90,121 | 28.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $3.4M | 57,410 | 20.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $3.1M | 11,404 | 19.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $2.9M | 32,911 | 17.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.0M | 267,000 | 6.4% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $399.0K | 4,441 | 2.4% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $387.0K | 42,019 | 2.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $383.0K | 11,130 | 2.3% |
| Spdr Series Trust(XBI) | S&P BIOTECH | 78464A870 | $9.0K | 130,000 | 0.1% |
| Ishares TR(IBB) | NASDQ BIOTEC ETF | 464287556 | $7.3K | 25,000 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $5.3K | 83,700 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $4.9K | 84,190 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $4.9K | 90,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $4.7K | 35,240 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $4.4K | 186,287 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $4.4K | 69,512 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN)Call | COM | 015351109 | $4.2K | 35,000 | 0.0% |
| Proshares TR(BIB) | PSHS ULT NASB | 74347R214 | $4.1K | 85,000 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $3.8K | 112,300 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $3.7K | 120,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $3.7K | 34,006 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $3.5K | 28,197 | 0.0% |
| Mettler Toledo International(MTD) | COM | 592688105 | $3.4K | 7,188 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $3.3K | 19,432 | 0.0% |
| Qiagen NV(QGEN) | SHS NEW | N72482123 | $3.2K | 111,763 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $3.2K | 19,401 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $3.2K | 78,900 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $3.1K | 8,035 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $2.5K | 60,000 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $2.4K | 45,000 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $2.3K | 50,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $2.3K | 18,701 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $1.9K | 30,000 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $1.5K | 80,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $1.5K | 10,000 | 0.0% |
| Medicines Co | COM | 584688105 | $1.4K | 28,000 | 0.0% |
| Lilly ELI & Co(LLY)Call | COM | 532457108 | $1.3K | 15,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $1.1K | 60,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $980 | 25,000 | 0.0% |
| New SR Invt Group Inc | COM | 648691103 | $854 | 83,700 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $827 | 12,201 | 0.0% |
| Gilead Sciences Inc(GILD)Call | COM | 375558103 | $679 | 10,000 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $540 | 300,000 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $476 | 31,748 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $466 | 5,931 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $441 | 50,463 | 0.0% |
| Direxion SHS ETF TR(LABUUSD) | SP BIOTCH BL NEW | 25490K323 | $416 | 8,723 | 0.0% |
| Grifols S A(GRFS) | SP ADR REP B NVT | 398438408 | $414 | 21,932 | 0.0% |
| Progenics Pharmaceuticals in | COM | 743187106 | $411 | 43,565 | 0.0% |
| Quintiles IMS Holdings Inc | COM | 74876Y101 | $405 | 5,027 | 0.0% |